Venrock Healthcare Capital Partners II, L.P. 13D/13G Filings for Altimmune, Inc. (ALT)

Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Altimmune, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
4:20 pm
Sale
2021-12-3113GALTIMMUNE INC
ALT
Venrock Healthcare Capital Partners II, L.P.1,760,870
4.200%
-1,862,094decrease
(-51.40%)
Filing